Careers at OXB

In a recent interview with The Medicine Maker, our CEO, Dr. Frank Mathias, shared what drives him. From his early days watching his father mix formulas in his pharmacy to leading OXB through its transformation into a pure-play CDMO, Frank reflects on the moments that shaped his career, the challenges and rewards of being a CEO, and the future of the advanced therapies field. "?????????? ???????? ???? ?????? ???????? ?????? ???????? ?????????????? ?????????? ???? ???? ???????????????????? ??????????????????. ?????????? ?????????????????? ???????? ?????? ?????????????????? ???? ???????? ????????-?????????????????????? ????????????????, ???????????????? ?????? ???????? ???? ???????????????? ?????? ???????????????????? ?????? ????????." One of the biggest shifts he sees? The industry’s growing reliance on CDMOs to accelerate innovation and make these life-changing therapies more accessible to patients worldwide. Read the full interview here: https://lnkd.in/e4kWSwXh ? #AdvancedTherapies #CellAndGeneTherapy #Leadership #InThoughtWithOXB #CDMO #OXB

We’re delighted to be named finalists in three categories at the Thames Valley Business Awards! ? ?? ?????????????????? ???? ?????? ???????? ??????????????????? ???? ?????? ???????? ?? ???????????????? ???????????? ???? ?????? ???????? ? Being recognised among so many outstanding businesses shaping the region is a great reminder of the impact innovation can have—not just in our industry, but in our local community too.? ? A huge thank you to our team, whose dedication continues to drive progress in advanced therapies. We’re looking forward to celebrating with all the nominees later this month!? ? #TVBCAwards #OXBInnovation #CellandGeneTherapy #AdvancedTherapies #OXB #CDMO?

We’re proud to share that we’ve been shortlisted for the ???????????????????????? ???? ?????? ???????? award at the ?????? ???????????? ????????!? ? This nomination reflects the significant strides we’ve made as a pure-play CDMO, and it’s a testament to our talented team’s hard work, commitment, and dedication to driving innovation in the field. At OXB, we remain focused on enabling our clients to deliver life-changing therapies to patients, and it’s an honour to see our progress recognised.? ? Good luck to all the nominees—we look forward to celebrating the achievements of this year’s finalists at the plc awards 2024 ceremony next month!? ? #PLCAwards #BreakthroughOfTheYear #OXBInnovation #OXB #CDMO?

What an inspiring week we had at Advanced Therapies 2025 in Dallas! From engaging conversations to meaningful new connections, our team found last week’s event to be a powerful showcase of the progress in the advanced therapies sector.? ? Sometimes, the cell and gene therapy world feels surprisingly small. That was the case when our team ran into Benjamin McLeod at the event. While reading about our new Dual-Plasmid Transfection System, Benjamin shared an unexpected connection: the research featured was developed by ?????? ???????? ?????????? ???????????????????? ???? ???????? ??????????????—?????? ???????? ???? ?????? ???????????????? ?????? ????????! It’s moments like these that remind us how collaboration and shared connections drive the breakthroughs that transform patient outcomes.? ? The innovation that sparked this connection with Benjamin was developed to address key challenges in manufacturing, ensuring greater scalability and consistency. You can explore?our Dual-Plasmid system?here: https://lnkd.in/efpwXduZ ? Thank you to everyone we met for the inspiring conversations—we’re excited to continue the dialogue. And a special thanks to Benjamin McLeod for sharing this wonderful story and making our week even more memorable!? ? #ATW25 #CellAndGeneTherapy #ViralVectors #OXBInnovation #SmallWorldBigImpact #MeetOXB #OXB

Great opportunity to join us in the FP&A team at OXB!

Sylvia MBemba #recrute. Connaissez-vous quelqu’un qui pourrait être intéressé ?

At OXB, we’re starting the year with gratitude for our partnerships and reflecting on the fantastic progress made in 2024. Here's to a new year of continued innovation, collaboration, and together, delivering impactful therapies to patients worldwide. We’d like to wish all our followers a successful and inspiring 2025. Let’s make it a year to remember! #TeamOXB #NewYearNewInnovations #Collaboration #CDMO #OXB

At the end of last year, our CEO, Dr. Frank Mathias shared an update on OXB’s transformation into a pure-play CDMO at the Jefferies Healthcare Conference. His presentation highlighted the progress we’re making on delivering on our One OXB strategy to better serve our clients, whilst building a world leading CDMO in cell and gene therapy. If you missed the session or would like to revisit it, you can watch the full presentation here:?https://lnkd.in/eYSNUrFQ ? #OXB #InnovationInFocus #JefferiesHealthcare #CDMOLeadership?

Check out this job at Oxford Biomedica: Senior Manager Supply Chain Management